Improved Prognosis for Mediastinal Germ Cell Tumours with Platinum-Based Chemotherapy
Author Information
Author(s): W.J. Childs, P. Goldstraw, J.E. Nicholls, D.P. Dearnaley, A. Horwich
Primary Institution: Royal Marsden Hospital
Hypothesis
Can platinum-based chemotherapy improve the prognosis of primary malignant germ cell tumours of the mediastinum?
Conclusion
The study found that patients with primary malignant mediastinal germ cell tumours have a high survival rate when treated with platinum-based chemotherapy and surgery.
Supporting Evidence
- All seven patients with seminoma remain alive and disease free, giving an overall survival of 100%.
- Complete remission was achieved in nine out of eleven patients with malignant teratoma, resulting in a survival rate of 75%.
- Patients with teratoma had very bulky disease and high serum tumour markers, which are known to predict poor prognosis.
Takeaway
Doctors found that using special medicines called platinum-based chemotherapy helped many boys with a rare type of cancer in their chest feel better and live longer.
Methodology
A retrospective analysis of patient records from 1977 to 1990 was conducted to assess the outcomes of patients treated with platinum-based chemotherapy.
Limitations
The study is limited by its retrospective nature and the small sample size.
Participant Demographics
All patients were male with a median age of 33 years.
Want to read the original?
Access the complete publication on the publisher's website